• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

可生物降解的基于聚乙烯醇的3D打印载体在溶解过程中的评估。

Evaluation of Biodegradable PVA-Based 3D Printed Carriers during Dissolution.

作者信息

Basa Bálint, Jakab Géza, Kállai-Szabó Nikolett, Borbás Bence, Fülöp Viktor, Balogh Emese, Antal István

机构信息

Department of Pharmaceutics, Semmelweis University, Hőgyes E. Street 7-9, 1092 Budapest, Hungary.

出版信息

Materials (Basel). 2021 Mar 11;14(6):1350. doi: 10.3390/ma14061350.

DOI:10.3390/ma14061350
PMID:33799585
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7998734/
Abstract

The presence of additive manufacturing, especially 3D printing, has the potential to revolutionize pharmaceutical manufacturing owing to the distinctive capabilities of personalized pharmaceutical manufacturing. This study's aim was to examine the behavior of commonly used polyvinyl alcohol (PVA) under in vitro dissolution conditions. Polylactic acid (PLA) was also used as a comparator. The carriers were designed and fabricated using computer-aided design (CAD). After printing the containers, the behavior of PVA under in vitro simulated biorelevant conditions was monitored by gravimetry and dynamic light scattering (DLS) methods. The results show that in all the dissolution media PVA carriers were dissolved; the particle size was under 300 nm. However, the dissolution rate was different in various dissolution media. In addition to studying the PVA, as drug delivery carriers, the kinetics of drug release were investigated. These dissolution test results accompanied with UV spectrophotometry tracking indirectly determine the possibilities for modifying the output of quality by computer design.

摘要

增材制造,尤其是3D打印的出现,由于其在个性化药物制造方面的独特能力,有可能彻底改变药物制造行业。本研究的目的是考察常用的聚乙烯醇(PVA)在体外溶解条件下的行为。聚乳酸(PLA)也用作对照物。载体采用计算机辅助设计(CAD)进行设计和制造。打印容器后,通过重量法和动态光散射(DLS)方法监测PVA在体外模拟生物相关条件下的行为。结果表明,在所有溶解介质中,PVA载体均被溶解;粒径在300nm以下。然而,在不同的溶解介质中,溶解速率有所不同。除了研究作为药物递送载体的PVA外,还研究了药物释放动力学。这些溶解试验结果与紫外分光光度法跟踪相结合,间接确定了通过计算机设计来改进质量输出的可能性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0b0/7998734/732f1f992a73/materials-14-01350-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0b0/7998734/47af90f9fa08/materials-14-01350-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0b0/7998734/a9447d9f45a0/materials-14-01350-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0b0/7998734/1e023e4d060f/materials-14-01350-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0b0/7998734/73b12718e51f/materials-14-01350-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0b0/7998734/d1e5f720eab8/materials-14-01350-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0b0/7998734/732f1f992a73/materials-14-01350-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0b0/7998734/47af90f9fa08/materials-14-01350-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0b0/7998734/a9447d9f45a0/materials-14-01350-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0b0/7998734/1e023e4d060f/materials-14-01350-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0b0/7998734/73b12718e51f/materials-14-01350-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0b0/7998734/d1e5f720eab8/materials-14-01350-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0b0/7998734/732f1f992a73/materials-14-01350-g006.jpg

相似文献

1
Evaluation of Biodegradable PVA-Based 3D Printed Carriers during Dissolution.可生物降解的基于聚乙烯醇的3D打印载体在溶解过程中的评估。
Materials (Basel). 2021 Mar 11;14(6):1350. doi: 10.3390/ma14061350.
2
Fused-filament 3D printing of drug products: Microstructure analysis and drug release characteristics of PVA-based caplets.基于 PVA 的片剂的药物产品熔融挤出 3D 打印:微观结构分析和药物释放特性。
Int J Pharm. 2016 Nov 30;514(1):290-295. doi: 10.1016/j.ijpharm.2016.06.021.
3
Supercritical Fluid Technology for the Development of 3D Printed Controlled Drug Release Dosage Forms.用于3D打印控释剂型开发的超临界流体技术
Pharmaceutics. 2021 Apr 13;13(4):543. doi: 10.3390/pharmaceutics13040543.
4
Fused Deposition Modelling 3D-Printed Gastro-Retentive Floating Device for Propranolol Hcl Tablets.用于盐酸普萘洛尔片的熔融沉积成型3D打印胃滞留漂浮装置
Polymers (Basel). 2023 Aug 26;15(17):3554. doi: 10.3390/polym15173554.
5
Defined drug release from 3D-printed composite tablets consisting of drug-loaded polyvinylalcohol and a water-soluble or water-insoluble polymer filler.从载药聚乙烯醇和水溶性或水不溶性聚合物填充剂组成的 3D 打印复合片剂中控制药物释放。
Int J Pharm. 2018 May 30;543(1-2):361-367. doi: 10.1016/j.ijpharm.2018.03.057. Epub 2018 Mar 29.
6
An investigation into the use of polymer blends to improve the printability of and regulate drug release from pharmaceutical solid dispersions prepared via fused deposition modeling (FDM) 3D printing.一项关于使用聚合物共混物来改善通过熔融沉积建模(FDM)3D打印制备的药物固体分散体的可印刷性并调节其药物释放的研究。
Eur J Pharm Biopharm. 2016 Nov;108:111-125. doi: 10.1016/j.ejpb.2016.08.016. Epub 2016 Sep 2.
7
A 3D printed bilayer oral solid dosage form combining metformin for prolonged and glimepiride for immediate drug delivery.一种 3D 打印双层口腔固体制剂,结合了用于延长释放的二甲双胍和用于即刻药物递送的格列美脲。
Eur J Pharm Sci. 2018 Jul 30;120:40-52. doi: 10.1016/j.ejps.2018.04.020. Epub 2018 Apr 17.
8
3D Printing of Metformin HCl PVA Tablets by Fused Deposition Modeling: Drug Loading, Tablet Design, and Dissolution Studies.熔融沉积成型法制备盐酸二甲双胍 PVA 片:载药量、片剂设计和溶出度研究。
AAPS PharmSciTech. 2019 May 22;20(5):195. doi: 10.1208/s12249-019-1400-5.
9
3D printing of PVA capsular devices for modified drug delivery: design and in vitro dissolution studies.用于改良药物递送的聚乙烯醇胶囊装置的3D打印:设计与体外溶出研究
Drug Dev Ind Pharm. 2020 Sep;46(9):1416-1426. doi: 10.1080/03639045.2020.1791166. Epub 2020 Jul 10.
10
3D printing of modified-release aminosalicylate (4-ASA and 5-ASA) tablets.缓释氨基水杨酸盐(4-氨基水杨酸和5-氨基水杨酸)片剂的3D打印
Eur J Pharm Biopharm. 2015 Jan;89:157-62. doi: 10.1016/j.ejpb.2014.12.003. Epub 2014 Dec 9.

引用本文的文献

1
Enhanced Transdermal Delivery of Lidocaine Hydrochloride via Dissolvable Microneedles (LH-DMNs) for Rapid Local Anesthesia.通过可溶解微针(LH-DMNs)增强盐酸利多卡因的透皮给药用于快速局部麻醉
Biosensors (Basel). 2025 Aug 21;15(8):552. doi: 10.3390/bios15080552.
2
Evaluation of 3D-Printed Balls with Photopolymer Resin as Grinding Medium Used to Alternatively Reduce Warmup During Dry Milling.以光聚合树脂为研磨介质的3D打印球在干式铣削中用于替代减少预热的评估。
Polymers (Basel). 2025 Jun 27;17(13):1795. doi: 10.3390/polym17131795.
3
Study on Lyophilised Orodispersible Tablets from Plant-Based Drinks as Bulking Agents.

本文引用的文献

1
Recent advances in the sustainable design and applications of biodegradable polymers.可生物降解聚合物的可持续设计与应用的最新进展。
Bioresour Technol. 2021 Apr;325:124739. doi: 10.1016/j.biortech.2021.124739. Epub 2021 Jan 20.
2
Fabrication of Drug-Eluting Nano-Hydroxylapatite Filled Polycaprolactone Nanocomposites Using Solution-Extrusion 3D Printing Technique.采用溶液挤出3D打印技术制备载药纳米羟基磷灰石填充聚己内酯纳米复合材料
Polymers (Basel). 2021 Jan 20;13(3):318. doi: 10.3390/polym13030318.
3
The Effects of Combined Infill Patterns on Mechanical Properties in FDM Process.
以植物饮料为填充剂的冻干口腔崩解片的研究
Pharmaceutics. 2025 Feb 4;17(2):195. doi: 10.3390/pharmaceutics17020195.
4
Three-Dimensional Printing of PVA Capsular Devices for Applications in Compounding Pharmacy: Effect of Design Parameters on Pharmaceutical Performance.用于复方制药的聚乙烯醇胶囊装置的三维打印:设计参数对药物性能的影响。
Pharmaceutics. 2024 Aug 15;16(8):1069. doi: 10.3390/pharmaceutics16081069.
5
Polyvinyl Alcohol, a Versatile Excipient for Pharmaceutical 3D Printing.聚乙烯醇,一种用于药物3D打印的多功能辅料。
Polymers (Basel). 2024 Feb 14;16(4):517. doi: 10.3390/polym16040517.
6
Engineering 3D-Printed Advanced Healthcare Materials for Periprosthetic Joint Infections.用于假体周围关节感染的工程化3D打印先进医疗材料。
Antibiotics (Basel). 2023 Jul 25;12(8):1229. doi: 10.3390/antibiotics12081229.
7
Additive manufacturing of sustainable biomaterials for biomedical applications.用于生物医学应用的可持续生物材料的增材制造。
Asian J Pharm Sci. 2023 May;18(3):100812. doi: 10.1016/j.ajps.2023.100812. Epub 2023 Apr 27.
8
Ex Vivo Transdermal Delivery of Nicotinamide Mononucleotide Using Polyvinyl Alcohol Microneedles.使用聚乙烯醇微针进行烟酰胺单核苷酸的离体透皮递送。
Polymers (Basel). 2023 Apr 25;15(9):2031. doi: 10.3390/polym15092031.
9
A Review of 3D Printing Technology in Pharmaceutics: Technology and Applications, Now and Future.制药领域3D打印技术综述:技术与应用,现状与未来
Pharmaceutics. 2023 Jan 26;15(2):416. doi: 10.3390/pharmaceutics15020416.
10
mRNA-Based Nanomedicinal Products to Address Corneal Inflammation by Interleukin-10 Supplementation.通过补充白细胞介素-10来治疗角膜炎症的基于信使核糖核酸的纳米药物产品。
Pharmaceutics. 2021 Sep 15;13(9):1472. doi: 10.3390/pharmaceutics13091472.
熔融沉积成型工艺中组合填充模式对力学性能的影响
Polymers (Basel). 2020 Nov 26;12(12):2792. doi: 10.3390/polym12122792.
4
3D Printing of Tunable Zero-Order Release Printlets.可调谐零级释放微印片的3D打印
Polymers (Basel). 2020 Aug 7;12(8):1769. doi: 10.3390/polym12081769.
5
Development of a 3D Printed Coating Shell to Control the Drug Release of Encapsulated Immediate-Release Tablets.用于控制包封速释片药物释放的3D打印包衣壳的研发。
Polymers (Basel). 2020 Jun 22;12(6):1395. doi: 10.3390/polym12061395.
6
Step-wise approach to developing a scale-independent design space for functional tablet coating process.建立一个适用于功能性片剂包衣工艺的无因次设计空间的逐步方法。
Drug Dev Ind Pharm. 2020 Apr;46(4):566-575. doi: 10.1080/03639045.2020.1742140. Epub 2020 Apr 1.
7
Impact of Processing Parameters on the Quality of Pharmaceutical Solid Dosage Forms Produced by Fused Deposition Modeling (FDM).加工参数对熔融沉积成型(FDM)制备的药物固体剂型质量的影响
Pharmaceutics. 2019 Nov 27;11(12):633. doi: 10.3390/pharmaceutics11120633.
8
Fused Deposition Modeling 3D Printing: Test Platforms for Evaluating Post-Fabrication Chemical Modifications and In-Vitro Biological Properties.熔融沉积建模3D打印:用于评估后加工化学修饰和体外生物学特性的测试平台
Pharmaceutics. 2019 Jun 13;11(6):277. doi: 10.3390/pharmaceutics11060277.
9
The Digital Pharmacies Era: How 3D Printing Technology Using Fused Deposition Modeling Can Become a Reality.数字药房时代:基于熔融沉积建模的3D打印技术如何成为现实。
Pharmaceutics. 2019 Mar 19;11(3):128. doi: 10.3390/pharmaceutics11030128.
10
In vitro and ex vivo studies on diltiazem hydrochloride-loaded microsponges in rectal gels for chronic anal fissures treatment.盐酸地尔硫䓬载入微球的直肠凝胶用于慢性肛裂治疗的体外和离体研究。
Int J Pharm. 2019 Feb 25;557:53-65. doi: 10.1016/j.ijpharm.2018.12.039. Epub 2018 Dec 21.